Kopra, Kari
Mahran, Randa
Yli-Hollo, Titta
Tabata, Sho
Vuorinen, Emmiliisa
Fujii, Yuki
Vuorinen, Iida
Ogawa-Iio, Aki
Hirayama, Akiyoshi
Soga, Tomoyoshi
Sasaki, Atsuo T.
Härmä, Harri
Funding for this research was provided by:
Japan Agency for Medical Research and Development (22ama221112h0001)
Uehara Memorial Foundation
Japan Society for the Promotion of Science (20H03165, 22J12765)
Academy of Finland (296093, 323433, 329012, 353324)
Human Frontier Science Program (RGP0028/2022)
Väisälä Fund
CREST program (JP20356709)
Japan Science and Technology Agency (JPMJFR2052)
Foundation for the National Institutes of Health (R01CA255331, R01GM144426, R01NS089815)
Otto. A. Malm foundation
University of Turku (UTU) including Turku University Central Hospital
Article History
Received: 2 August 2023
Revised: 4 September 2023
Accepted: 7 September 2023
First Online: 16 September 2023
Declarations
:
: The authors declare the following competing financial interest(s): Kari Kopra and Harri Härmä have commercial interest through QRET Technologies Ltd. Randa Mahran, Titta Yli-Hollo, Sho Tabata, Emmiliisa Vuorinen, Yuki Fujii, Iida Vuorinen, Aki Ogawa-Iio, Akiyoshi Hirayama, Tomoyoshi Soga, and Atsuo T. Sasaki declare that they have no relevant financial or non-financial interests to disclose.